RAFAEL HOLDINGS, INC. Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
RAFAEL HOLDINGS, INC. (RFL) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of -$1.76 million for the 3-month period ending 2023-04-30, per its 10-Q filed 2023-06-13.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2023-06-13
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2023-04-30 was -$1.76M.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2022-10-31 was $1.59M.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2022-07-31 was -$7.12M.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2022-04-30 was -$4.98M.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2022 was -$142.44M.
- RAFAEL HOLDINGS, INC. other comprehensive income (loss), before reclassifications, net of tax for fiscal 2021 was -$24.76M.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 9 month as first filed | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month |
|---|---|---|---|---|---|---|
| 2023-04-30 | -$1.76M 10-Q · filed 2023-06-13 | -$10.21M 10-Q · filed 2023-06-13 | ||||
| 2022-10-31 | $1.59M 10-Q · filed 2022-12-13 | -$5.53M derived: sum of 2 quarters · filed 2022-12-13 | -$10.51M derived: sum of 3 quarters · filed 2023-06-13 | -$12.93M derived: sum of 4 quarters · filed 2023-06-13 | ||
| 2022-07-31 | -$7.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | -$12.10M derived: sum of 2 quarters · filed 2023-06-13 | -$14.52M derived: sum of 3 quarters · filed 2023-06-13 | -$142.44M 10-K · filed 2022-10-31 | ||
| 2022-04-30 | -$4.98M 10-Q · filed 2023-06-13 | -$5.76M 10-Q · filed 2022-06-14 | -$7.40M derived: sum of 2 quarters · filed 2023-06-13 | -$135.33M 10-Q · filed 2023-06-13 | -$137.58M 10-Q · filed 2022-06-14 | -$149.24M derived: sum of 4 quarters · filed 2023-06-13 |
| 2022-01-31 | -$2.42M 10-Q · filed 2022-03-17 | -$131.82M 10-Q · filed 2022-03-17 | -$144.26M derived: sum of 3 quarters · filed 2022-12-13 | -$146.91M derived: sum of 4 quarters · filed 2022-12-13 | ||
| 2021-10-31 | -$129.40M 10-Q · filed 2022-12-13 | -$141.84M derived: sum of 2 quarters · filed 2022-12-13 | -$144.49M derived: sum of 3 quarters · filed 2022-12-13 | -$152.69M derived: sum of 4 quarters · filed 2022-12-13 | ||
| 2021-07-31 | -$12.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | -$15.09M derived: sum of 2 quarters · filed 2022-10-31 | -$23.29M derived: sum of 3 quarters · filed 2022-10-31 | -$24.76M 10-K · filed 2022-10-31 | ||
| 2021-04-30 | -$2.65M 10-Q · filed 2022-06-14 | -$10.85M derived: sum of 2 quarters · filed 2022-06-14 | -$12.31M 10-Q · filed 2022-06-14 | |||
| 2021-01-31 | -$8.20M 10-Q · filed 2022-03-17 | -$9.67M 10-Q · filed 2022-03-17 | ||||
| 2020-10-31 | -$1.47M 10-Q/A · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |